These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 16458605

  • 1. HIV-specific CD4+ T cells and viremia: who's in control?
    Jansen CA, van Baarle D, Miedema F.
    Trends Immunol; 2006 Mar; 27(3):119-24. PubMed ID: 16458605
    [Abstract] [Full Text] [Related]

  • 2. High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.
    McNeil AC, Shupert WL, Iyasere CA, Hallahan CW, Mican JA, Davey RT, Connors M.
    Proc Natl Acad Sci U S A; 2001 Nov 20; 98(24):13878-83. PubMed ID: 11717444
    [Abstract] [Full Text] [Related]

  • 3. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P, Joos B, Niederöst B, Weber R, Günthard HF, Fischer M.
    J Virol; 2007 Sep 20; 81(18):9693-706. PubMed ID: 17609262
    [Abstract] [Full Text] [Related]

  • 4. HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity.
    Younes SA, Yassine-Diab B, Dumont AR, Boulassel MR, Grossman Z, Routy JP, Sekaly RP.
    J Exp Med; 2003 Dec 15; 198(12):1909-22. PubMed ID: 14676302
    [Abstract] [Full Text] [Related]

  • 5. The value of preserving HIV-specific immune responses.
    Kaufmann DE, Rosenberg ES.
    J HIV Ther; 2003 Feb 15; 8(1):19-25. PubMed ID: 12840711
    [Abstract] [Full Text] [Related]

  • 6. Opportunistic infection as a cause of transient viremia in chronically infected HIV patients under treatment with HAART.
    Jones LE, Perelson AS.
    Bull Math Biol; 2005 Nov 15; 67(6):1227-51. PubMed ID: 16023709
    [Abstract] [Full Text] [Related]

  • 7. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA, Ono E, Machado DM, Brunialti M, Succi RC, Salomão R, Kallás EG, de Moraes-Pinto MI.
    Cytometry B Clin Cytom; 2007 Jan 15; 72(1):14-21. PubMed ID: 17041945
    [Abstract] [Full Text] [Related]

  • 8. Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients.
    Keh CE, Shen JM, Hahn B, Hallahan CW, Rehm CA, Thaker V, Wynne SM, Davey RT, Lane HC, Sereti I.
    AIDS; 2006 Feb 14; 20(3):361-9. PubMed ID: 16439869
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy.
    Siddique MA, Hartman KE, Dragileva E, Dondero M, Gebretsadik T, Shintani A, Peiperl L, Valentine F, Kalams SA.
    J Infect Dis; 2006 Sep 01; 194(5):661-5. PubMed ID: 16897665
    [Abstract] [Full Text] [Related]

  • 12. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus.
    Altfeld M, Allen TM, Yu XG, Johnston MN, Agrawal D, Korber BT, Montefiori DC, O'Connor DH, Davis BT, Lee PK, Maier EL, Harlow J, Goulder PJ, Brander C, Rosenberg ES, Walker BD.
    Nature; 2002 Nov 28; 420(6914):434-9. PubMed ID: 12459786
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.
    Ostrowski SR, Katzenstein TL, Pedersen BK, Gerstoft J, Ullum H.
    Scand J Immunol; 2008 Dec 28; 68(6):652-60. PubMed ID: 19055701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.